Glaukos (GKOS) logo

Glaukos (GKOS) insider trading in the last 6 months

Form 4 filings, newest first

Quality Score today 16

4 insiders sold $15.2M. No buys.

SellTomas Navratil$1.4MChief Development Officerat $180.25 on Aug 28, filed Sep 1
SellTomas Navratil$1.1MChief Development Officerat $181.19 on Aug 28, filed Sep 1
SellTomas Navratil$2KChief Development Officerat $182.50 on Aug 28, filed Sep 1

From SEC Form 4s, the newest filed Sep 1, 2026 · Insiders have 2 business days to file a trade

6 more filings on GKOS in the last 6 months, for Pro members. See them free →

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 9 tradesSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Pro members see every filing on GKOS with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at Glaukos

Insider trades by person

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Questions about GKOS's insider trades

As of Nov 3, 2026: Glaukos (GKOS) has 9 insider filings on record in the last 6 months, the newest filed Sep 1, 2026. Its Quality Score is 16 (Excellent). Scores as of 7:49 PM ET, 15 minutes behind.

Are GKOS insiders buying or selling?

4 insiders sold $15.2M across 9 filings in the last 6 months. No open-⁠market buys on record. The newest filing: Tomas Navratil, Chief Development Officer, sold $1.4M on Aug 28, 2026.

Who are GKOS's biggest insider sellers?

By the dollars of their sales in the last 6 months: Joseph E. Gilliam (President & COO), 2 sales; Tomas Navratil (Chief Development Officer), 3 sales; Gilbert H. Kliman (Director), 3 sales. 4 insiders sold in all.

When did a GKOS insider last buy?

No GKOS insider bought shares on the open market in the last 6 months, as filed on Form 4. The newest filing is a sale by Tomas Navratil on Aug 28, 2026.

Glaukos's page has its Quality Score, its chart, and its earnings. More in Healthcare and Medical Devices.

Shares insiders bought or sold themselves, as filed on Form 4. Grants, option exercises, shares withheld for tax, and 10b5-1 plan sales are left out.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.